China Universal Asset Management Co., Ltd. Kymera Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,422 shares of KYMR stock, worth $570,790. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,422
Previous 7,208
72.34%
Holding current value
$570,790
Previous $215,000
173.02%
% of portfolio
0.07%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$305 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$276 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$237 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$225 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$218 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.51B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...